Skip to main content

Table 2 Comparison of the demographic and clinical data of patients in each group

From: Dysregulation of miR-210 is involved in the development of diabetic retinopathy and serves a regulatory role in retinal vascular endothelial cell proliferation

GroupAge (year)Gender (male/female)BMI (kg/m2)Disease course (year)FPG (mmol/l)TG (mmol/l)TC (mmol/l)HbA1c (%)FINS (mIU/I)HOMA-IR
HC50.85±5.2028/3221.81±2.205.14 ± 0.831.47±0.174.28±0.494.92±0.465.38±0.541.29±0.08
  1. Data are expressed as the mean ± SD or number. Multiple comparisons were made using ANOVA followed by Tamhane’s T2 tests, while the gender distribution among groups were evaluated by using Chi-square test
  2. HC healthy control, NDR DM without DR patients, NPDR non-proliferative DR, PDR proliferative DR, FPG fasting plasma glucose, TG triacylglycerol, TC total cholesterol, HbA1c glycosylated hemoglobin, FINS fasting insulin, HOMA-IR homoeostasis model assessment of insulin resistance
  3. *P < 0.05 compared with HC group; #P < 0.05 compared with NDR group; &P < 0.05 compared with NPDR group